| Literature DB >> 34069197 |
Rubal Chahal1, Arun Nanda1, Esra Küpeli Akkol2, Eduardo Sobarzo-Sánchez3,4, Ashwani Arya1, Deepak Kaushik1, Rohit Dutt5, Rashmi Bhardwaj6, Md Habibur Rahman7, Vineet Mittal1.
Abstract
Ageratum conyzoides L. (Family-Asteraceae) is an annual aromatic invasive herb, mainly distributed over the tropical and subtropical regions of the world. It owns a reputed history of indigenous remedial uses, including as a wound dressing, an antimicrobial, and mouthwash as well as in treatment of dysentery, diarrhea, skin diseases, etc. In this review, the core idea is to present the antifungal potential of the selected medicinal plant and its secondary metabolites against different fungal pathogens. Additionally, toxicological studies (safety profile) conducted on the amazing plant A. conyzoides L. are discussed for the possible clinical development of this medicinal herb. Articles available from 2000 to 2020 were reviewed in detail to exhibit recent appraisals of the antifungal properties of A. conyzoides. Efforts were aimed at delivering evidences for the medicinal application of A. conyzoides by using globally recognized scientific search engines and databases so that an efficient approach for filling the lacunae in the research and development of antifungal drugs can be adopted. After analyzing the literature, it can be reported that the selected medicinal plant effectively suppressed the growth of numerous fungal species, such as Aspergillus, Alternaria, Candida, Fusarium, Phytophthora, and Pythium, owing to the presence of various secondary metabolites, particularly chromenes, terpenoids, flavonoids and coumarins. The possible mechanism of action of different secondary metabolites of the plant against fungal pathogens is also discussed briefly. However, it was found that only a few studies have been performed to demonstrate the plant's dosage and safety profile in humans. Considered all together, A. conyzoides extract and its constituents may act as a promising biosource for the development of effective antifungal formulations for clinical use. However, in order to establish safety and efficacy, additional scientific research is required to explore chronic toxicological effects of ageratum, to determine the probability of interactions when used with different herbs, and to identify safe dosage. The particulars presented here not only bridge this gap but also furnish future research strategies for the investigators in microbiology, ethno-pharmacology, and drug discovery.Entities:
Keywords: Ageratum conyzoides; clinical applications; ethnomedicinal uses; fungal pathogens; precocene; toxicity
Year: 2021 PMID: 34069197 PMCID: PMC8156077 DOI: 10.3390/molecules26102933
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Ageratum conyzoides L. (Picture was taken in the month of April from the agricultural land in Jammu, India.).
Traditional uses of Ageratum conyzoides L.
| Country | Traditional Uses | Plant Part/Medicinal Preparation(s)/Doses | Reference(s) |
|---|---|---|---|
| Nigeria | Diarrhea | Plant decoction of leaves and aerial branches of | [ |
| Diabetes | Whole plant/macerated with two other herbs— | ||
| Earache | Warm leaves exudate squeezed as ear drops | ||
| Eaten by Igbo communities | Part of “olulu-ogwai” soup | [ | |
| Brazil | Diarrhea, menstrual cramps, rheumatism, and arthritis | Aerial parts (dried or fresh, externally and internally as infusions or tinctures) and in medicinal teas | [ |
| Analgesic and anti-inflammatory | [ | ||
| Cameroon | Syphilis condition | Leaves (mixed with other herbs) | [ |
| Craw-craw (itching skin disease) | NS | [ | |
| Ghana | Eyetroubles | Rub and squeeze (Topical) | [ |
| Antifungal and antibacterial | NS | [ | |
| To augment hair growth and in constipation (as an enema) | Children’s eyebrows scrubbed with charcoal punched young stems of plant | [ | |
| Western Nepal | Wounds and cuts | Juice of leaves | [ |
| Gabon | In helminthiasis | Decoction of leaves | [ |
| and malaria | NS | [ | |
| Congo | Treating chronic pain, analgesic, antimicrobial, and anti-inflammatory | Leaf extract | [ |
| African countries | To cure contagious and psychological diseases, diabetes, snake bite antidote | NS | [ |
| Pneumonia, wounds, and burns | NS | [ | |
| Cure scabies, anti-asthmatic, dyspnea, antispasmodic, and hemostatic effects | NS | [ | |
| Tanzania | Stomachache | Leaves are chewed | [ |
| Wound healing | Pounded fresh leaves | ||
| Cough and chest congestion | Roots | ||
| Indonesia | Against fungal infection | NS | [ |
| Wounds, eczema, ulcers and in bacterial infections | NS | [ | |
| India | To stop bleeding | Leaf extract | [ |
| Anthelmintic and wound healing | Stem and Leaf | [ | |
| Wounds and cuts | Leaf paste | [ | |
| Eye discharge and leprosy | Oil lotion | [ |
* NS; Not stated.
Figure 2Chemical constituents of Ageratum conyzoides with antifungal activity.
Antifungal activities by main constituents extracted from Ageratum conyzoides.
| Chemical Constituent | Fungal Strain Investigated | Inference/Mechanism of Action | Reference(s) |
|---|---|---|---|
| Precocene II | [ | ||
| Precocene II |
| Fungal growth was restricted to different extents, and aflatoxin production was inhibited completely above concentrations of 0.10 µg/mL. | [ |
| Precocene II |
|
Superoxide level was augmented in mitochondria, and eventually, trichothecene production was inhibited in | [ |
| Precocene II |
| Among the three oils investigated (5.0 μL; from 3 different locations), the oils with more precocene II concentration inhibited the fungal growth effectively. | [ |
| Eugenol |
|
Various eugenol concentrations (0, 25, 50, 100, 150, and 200 μg/mL) inhibited | [ |
| Eugenol | At sub-MICs (6.25–100 mM), eugenol inhibited the formation of germ tube by | [ | |
| Eugenol | Order of sensitivity: | [ | |
| Eugenol and β-caryophyllene | 53 human pathogenic yeasts (All candida species) | Bud oil, 10 mg per disc, was reported effective against all the fungal strains investigated. | [ |
| Eugenol |
| MIC (minimum inhibitory concentrations) and MIF (minimum fungicidal concentrations) for eugenol was reported as 0.4 μL/mL and 0.8 μL/mL, respectively. | [ |
| β-caryophyllene | β-caryophyllene demonstrated a rapid and efficient fungicidal action within 4–8 h and 2–4 h for | [ | |
| β-caryophyllene | β-caryophyllene was observed with a more pronounced antifungal effect than kanamycin, standard reference. | [ | |
| Coumarin |
| Coumarin showed a clear inhibition zone up to 72 h as compared with 24 h of miconazole nitrate. Among various coumarin concentrations tested (31.25, 62.5, 125, 250, 500, 1000 µg mL−1 in dichloromethane), MIC reported was 125 μg/mL. | [ |
| Coumarin |
| Different coumarin concentrations, i.e., 0.5, 1.0, and 2.0 mg/mL, significantly inhibited fungal growth in a dose-dependent manner. This constituent induced a sequence of apoptotic features such as phosphatidylserine (PS) externalization, fragmenting DNA, and condensing nucleus. | [ |
Figure 3Various pathogenic fungal strains sensitive to Ageratum extracts/oils.
Figure 4Effect of various Ageratum oil/constituents/extracts on fungal cell morphology.
Evidence of the activity of essential oil/different extracts from Ageratum conyzoides against important fungal strains.
| Plant Part Used | Type of Extract (Conc.) | Fungal Strains | Inference | References |
|---|---|---|---|---|
| Leaves | Aqueous extracts | Leaf extract inhibited radial growth and conidia germination significantly in comparison with the control. However, sporulation of | [ | |
| Leaves | Aqueous total extract, |
| Among the three extracts investigated, 70% ethanolic fraction of leaves showed higher level activity against the fungal colony in comparison with the other extracts. | [ |
| Whole parts | Methanol crude extract | At concentrations of 2.5% and 5.0%, | [ | |
| Leaves | Aqueous extracts | [ | ||
| Leaves | Petroleum ether and methanolic extracts | Pet. ether extract of the plant significantly inhibited the growth of all the fungi examined. Extract was found better even than the synthetic fungicides (Indofil M-45, Blitox-50, and Mancozeb except Dhanustin) when compared for mycelial growth percentage inhibition. | [ | |
| Aerial parts (leaves and stem) (Cameroon) | Aqueous extracts (5,10, 15, 20 mg/mL) and ethanolic extracts | For ethanolic extract, complete (100%) growth inhibition of both the fungi was reported at 10 mg/mL concentration. For aqueous extracts, a concentration of 20 mg/mL completely inhibited the | [ | |
| Root, shoot, and leaf | Essential oils, aqueous extracts, and dichloromethane (DCM) fraction | The order of activity against the fungal growth was observed as, essential oil > dichloromethane extract > aqueous extract. | [ | |
| Leaves | Concentrated hexane extract | Extracts of | [ | |
| Leaves | Essential oil | Study revealed the potential of | [ | |
| Leaves | Essential oil | Precocene I (96.53%) and precocene II (2.40%) were the key constituents reported in the oil. | [ | |
| Leaves | Hydroalcoholic extract | After exposure to | [ | |
| Whole plant | Essential oil, cold water, hot water, and ethanol extract | Highest mycelial inhibitory potential was demonstrated with essential oil, followed by the ethanolic extract. Fungicidal activity for ethanolic extract was observed at a concentration of 5000 ppm. | [ | |
| Whole plant | Methanol, ethyl acetate, benzene chloroform, and acetone extracts | The fungus examined was observed to be highly sensitive toward the chloroform and methanolic extracts, with a minimum inhibitory concentration of 3.125 × 10−5 μL/mL and 6.25 × 10−4 μL/mL. | [ | |
| Aerial parts | Essential oil | The essential oil (10 to 90%) exhibited a varied zone of inhibition against R. solani (5.00 to 10.00 mm), | [ | |
| Leaves | Essential oil | Toxigenic strain, | Study confirmed the broad fungi static spectrum owned by the oil. | [ |
| Shoot and root extracts | Aqueous extract | At varied concentrations (2–6%), | [ | |
| Shoots | Sequentially extracted with | MIC communicated for | [ | |
| Whole plant | The inter-cropped plants of | [ | ||
| Root and shoot | Aqueous extract | [ | ||
| Shoots | Aqueous extracts (3 mL plant extract with 20 mL potato Dextrose agar) | Except | [ | |
| Leaves | Crude extract (1, 5,10, 15, 20, 25, and 50%); | Inhibition of fungal mycelial growth and spore germination varied with various concentrations of crude extract used. | [ | |
| Leaves | Essential oil | Among the plants of 30 species screened, vapors from | [ | |
| Leaves | Essential oil |
| At minimum inhibitory concentration, 250 μg/L, oil inhibited the mycelial growth entirely. | [ |
Figure 5Lacunae observed in the clinical establishment of Ageratum conyzoides.